Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2024)

Illumina (ILMN) reported Asset Writedowns and Impairment of $1.9 billion for Q2 2024, up 31333.33% quarter-over-quarter from $6.0 million in Q4 2023.

Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2024) Analysis & Trends

Illumina has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $1.9 billion in Q2 2024.

For the quarter ending Q2 2024, Asset Writedowns and Impairment changed N/A year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2025 stood at $1.9 billion (down 30.48% YoY), and the FY2024 full-year result was $1.9 billion, up 128.42% from the prior year.
Asset Writedowns and Impairment for Q2 2024 stood at $1.9 billion, up from $6.0 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $1.9 billion in Q2 2024, with the low at $6.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Quest Diagnostics	22.51 Bn	22.42 Bn	942.00 Mn

Download Data